FindTrial
Sign In

Studying how Gamma Knife treatment affects health outcomes in children with retinoblastoma

Clinical outcomes of Gamma Knife Radiosurgery in Retinoblastoma - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098463
Enrollment
15
Registered
2025-12-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C692- Malignant neoplasm of retina

Interventions

Intervention1: Gamma knife radiosurgery: 2.5 YEARS Control Intervention1: Nil: Nil

Sponsors

DR MEGHA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Tumour that failed conventional treatment. Tumour recurrence Refusal of enucleation

Exclusion criteria

Exclusion criteria: Retinoblastoma with extra ocular extension. Treatment naive cases

Design outcomes

Primary

MeasureTime frame
Clinical outcomes will be measured based on 2 parameters 1. Efficacy 2. SafetyTimepoint: 2.5 years—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Bhavna Chawla

Dr. Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS

Bhavna2424@hotmail.com9654842424

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026